cdmo.directory
← Compare landing

Ascendia Pharmaceutical Solutions vs Delpharm

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/ascendiapharma/delpharm

CategoryAscendia Pharmaceutical SolutionsDelpharm
Listed sitecdmocdmo
SummarySpecialty CDMO offering formulation development, analytical services, and cGMP manufacturing for small molecules and biologics from preclinical through Phase 1 and commercialization.Top-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually.
Services
  • Formulation Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Process Development
  • Quality Control Testing
  • Technology Transfer
  • Lipid Nanoparticle (LNP) Formulation
  • Peptide Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Oral Solid Dosage Manufacturing
  • Lyophilization (Freeze Drying)
  • Vial Filling
  • Sterile Fill-Finish & Aseptic Manufacturing
  • CMC Regulatory Submission Support
  • Prefilled Syringe (PFS) Filling
  • Oral Solid Dosage Manufacturing
  • Topical & Semi-Solid Manufacturing
  • Prefilled Syringe (PFS) Filling
  • Vial Filling
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Inhalation & Nasal Dosage Manufacturing
  • Secondary Packaging & Labeling
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • Stability Testing & Storage
  • Lyophilization (Freeze Drying)
Modalities
  • Small Molecule
  • Biologics (Other)
  • mRNA
  • Gene Therapy
  • Small Molecule
  • Biologics (Other)
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters / New Jersey Bioscience Center, North Brunswick, New Jersey, United States
  • Headquarters, Boulogne-Billancourt, Île-de-France, France
  • Production Site, Bladel, Netherlands
  • Production Site, Brétigny, Île-de-France, France
  • Production Site, Dijon, Bourgogne-Franche-Comté, France
  • Production Site, Evreux, Normandie, France
  • Production Site, Gaillard, Auvergne-Rhône-Alpes, France
  • Production Site, Huningue, Grand Est, France
  • Production Site, L'Aigle, Normandie, France
  • Production Site, Lille, Hauts-de-France, France
  • Production Site, Milano, Lombardy, Italy
  • Production Site, Montréal, Quebec, Canada
  • Production Site, Novara, Piedmont, Italy
  • Production Site, Orléans, Centre-Val de Loire, France
  • Production Site, Reims, Grand Est, France
  • Production Site, Saint-Rémy, France
  • Production Site, Tours, Centre-Val de Loire, France
  • Brétigny, Brétigny, Île-de-France, France
  • Dijon, Dijon, Bourgogne, France
  • Evreux, Evreux, Normandy, France
  • Gaillard, Gaillard, Auvergne-Rhône-Alpes, France
  • L'Aigle, L'Aigle, Normandy, France
  • Lille, Lille, Hauts-de-France, France
  • Orléans, Orléans, Centre-Val de Loire, France
  • Reims, Reims, Grand Est, France
  • Tours, Tours, Centre-Val de Loire, France
  • Huningue, Huningue, Grand Est, France
  • Bladel, Bladel, North Brabant, Netherlands
  • Meppel, Meppel, Drenthe, Netherlands
  • Milano, Milano, Lombardy, Italy
  • Novara, Novara, Piedmont, Italy
  • Poznań, Poznań, Greater Poland, Poland
  • Saint-Rémy, Saint-Rémy, Auvergne-Rhône-Alpes, France
  • Boucherville, Boucherville, Quebec, Canada
  • Montréal, Montréal, Quebec, Canada
  • Montreal, Montreal, Quebec, Canada
  • Milano, Milan, Lombardy, Italy
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.